SFERA Archivio dei prodotti della Ricerca dell'Università di Ferrara

CAPUTO, Antonella
 Distribuzione geografica
Salva come PNG Salva come JPEG
Continente #
NA - Nord America 8.478
AS - Asia 4.284
EU - Europa 4.018
SA - Sud America 720
AF - Africa 76
OC - Oceania 8
Continente sconosciuto - Info sul continente non disponibili 3
Totale 17.587
Salva come PNG Salva come JPEG
Nazione #
US - Stati Uniti d'America 8.332
SG - Singapore 1.819
PL - Polonia 1.754
CN - Cina 1.226
BR - Brasile 608
IT - Italia 556
UA - Ucraina 435
DE - Germania 430
HK - Hong Kong 416
TR - Turchia 308
GB - Regno Unito 238
VN - Vietnam 238
RU - Federazione Russa 139
FI - Finlandia 111
SE - Svezia 106
ID - Indonesia 78
CA - Canada 70
MX - Messico 64
AR - Argentina 58
FR - Francia 58
IN - India 53
NL - Olanda 48
BE - Belgio 35
ZA - Sudafrica 34
AT - Austria 26
BD - Bangladesh 24
IQ - Iraq 22
EC - Ecuador 21
JP - Giappone 20
LT - Lituania 19
ES - Italia 18
CZ - Repubblica Ceca 15
RO - Romania 11
CO - Colombia 10
IR - Iran 10
MA - Marocco 10
KE - Kenya 9
PK - Pakistan 9
IL - Israele 8
PY - Paraguay 7
SA - Arabia Saudita 7
TN - Tunisia 7
EG - Egitto 6
IE - Irlanda 6
KZ - Kazakistan 6
UZ - Uzbekistan 6
VE - Venezuela 6
AE - Emirati Arabi Uniti 5
AU - Australia 5
CH - Svizzera 5
JO - Giordania 5
DZ - Algeria 4
LB - Libano 4
OM - Oman 4
PE - Perù 4
AL - Albania 3
JM - Giamaica 3
A2 - ???statistics.table.value.countryCode.A2??? 2
CL - Cile 2
GT - Guatemala 2
KH - Cambogia 2
KR - Corea 2
MY - Malesia 2
NG - Nigeria 2
NZ - Nuova Zelanda 2
PA - Panama 2
PH - Filippine 2
TT - Trinidad e Tobago 2
UY - Uruguay 2
AO - Angola 1
BO - Bolivia 1
BY - Bielorussia 1
CY - Cipro 1
DM - Dominica 1
DO - Repubblica Dominicana 1
EU - Europa 1
GA - Gabon 1
GR - Grecia 1
GY - Guiana 1
HN - Honduras 1
HU - Ungheria 1
KW - Kuwait 1
LK - Sri Lanka 1
MG - Madagascar 1
MN - Mongolia 1
NO - Norvegia 1
NP - Nepal 1
PS - Palestinian Territory 1
PW - Palau 1
QA - Qatar 1
RS - Serbia 1
SN - Senegal 1
SY - Repubblica araba siriana 1
Totale 17.587
Salva come PNG Salva come JPEG
Città #
Warsaw 1.751
Fairfield 948
Singapore 936
Ashburn 868
Woodbridge 759
Houston 556
Beijing 462
Santa Clara 430
Hong Kong 415
Jacksonville 401
Seattle 377
Chandler 369
Wilmington 344
Ann Arbor 342
Cambridge 328
Izmir 237
Ferrara 204
Princeton 173
Nanjing 161
New York 158
Dallas 135
Los Angeles 127
San Diego 107
The Dalles 98
Munich 95
Milan 70
Shanghai 64
Ho Chi Minh City 63
Jakarta 57
São Paulo 48
Hanoi 45
Bologna 44
Boardman 42
Nanchang 41
Mexico City 40
London 37
Shenyang 37
Hebei 36
Tianjin 36
Brussels 35
Dong Ket 34
Buffalo 33
Jiaxing 33
Chicago 30
Changsha 28
Montreal 28
Rome 28
Brooklyn 27
Dearborn 27
Nuremberg 25
Rio de Janeiro 25
Turku 25
Falls Church 24
San Francisco 24
Boston 23
Hefei 23
Norwalk 22
Phoenix 22
Falkenstein 21
Jinan 21
Mountain View 21
Tokyo 20
Belo Horizonte 19
Helsinki 19
Stockholm 19
Moscow 18
Orange 18
Atlanta 17
Chennai 17
Redwood City 17
Amsterdam 16
Johannesburg 15
Kunming 15
San Mateo 15
Denver 14
Manchester 14
Modena 14
Porto Alegre 14
Frankfurt am Main 13
Orem 13
Poplar 13
Toronto 13
Auburn Hills 12
Brno 12
Da Nang 12
Des Moines 12
Ningbo 12
Ottawa 11
Ankara 10
Goiânia 10
Haiphong 10
Taizhou 10
Washington 10
Brasília 9
Ferrara di Monte Baldo 9
Salt Lake City 9
Augusta 8
Baghdad 8
Columbus 8
Guarulhos 8
Totale 12.533
Salva come PNG Salva come JPEG
Nome #
HIV-1 Tat protein modulates the generation of cytotoxic T cell epitopes by modifying proteasome composition and enzymatic activity 341
Identification of new HIV-1 Gag-specific cytotoxic T lymphocyte responses in BALB/c mice 317
BK virus-plasmid expression vector that persists episomally in human cells and shuttles into Escherichia coli 299
Biocompatible anionic polymeric microspheres as priming delivery system for effetive HIV/AIDS tat-based vaccines 274
Candidate HIV-1 Tat vaccine development: From basic science to clinical trials 271
HIV-1 tat addresses dendritic cells to induce a predominant th1-type adaptive immune response that appears prevalent in the asymptomatic stage of infection 246
The presence of anti-Tat antibodies is predictive of long-term nonprogression to AIDS or severe immunodeficiency: Findings in a cohort of HIV-1 seroconverters 244
Long-term protection against SHIV89.6P replication in HIV-1 Tat vaccinated cynomolgus monkeys 239
Effects of different routes of administration on the immunogenicity of the Tat protein and a Tat-derived peptide 230
The HIV-1 Tat protein induces the activation of CD8+ T cells and affects in vivo the magnitude and kinetics of antiviral responses. 229
Systemic immunodominant CD8 responses with an effector-like phenotype are induced by intravaginal immunization with attenuated HSV vectors expressing HIV Tat and mediate protection against HSV infection 220
Cationic PMMA nanoparticles bind and deliver antisense oligoribonucleotides allowing restoration of dystrophin expression in the mdx mouse 220
An Attenuated Herpes Simplex Virus Type 1 (HSV1) Encoding the HIV-1 Tat Protein Protects Mice from a Deadly Mucosal HSV1 Challenge 211
Recombinant herpes simplex virus and uses therefor 196
Nanoparticles for delivery of a pharmacologically active agent 195
The HIV-1 Tat protein affects human CD4+ T cell programming and activation, and favors the differentiation of naïve CD4+ T cells 186
null 183
null 179
The Tat protein broadens T cell responses directed to the HIV-1 antigens Gag and Env: Implications for the design of new vaccination strategies against AIDS 172
Episomal DNA of a BK virus variant in a human insulinoma 168
null 167
Morphological, histochemical, immunohistochemical, and ultrastructural characterization of tumors and dysplastic and non-neoplastic lesions arising in BK virus/tat transgenic mice 164
Containment of infection in Tat vaccinated monkeys after rechallenge with a higher dose of SHIV89.6Pcy243 164
Priming with a very low dose of DNA complexed with cationic block copolymers followed by protein boost elicits broad and long-lasting antigen-specific humoral and cellular responses in mice 163
Age-related decline of de novo T cell responsiveness as a cause of COVID-19 severity 161
Antiangiogenic, antitumoural and antimetastatic effects of two distamycin A derivatives with anti-HIV-1 Tat activity in a Kaposi's sarcoma-like murine model 159
Inhibition of HIV-1 replication by a Tat transdominant negative mutant in human peripheral blood lymphocytes from healthy donors and HIV-1-infected patients 159
T.P.2.07 The systemic administration of a low dose of 2OMePS-AON combined with novel cationic polymethylmethacrylate nanoparticles induces the rescue of dystrophin expression in the mdx murine model 158
High expression of exogenous cDNAs directed by HIV-1 long terminal repeat in human cells constitutively producing HIV-1 tat and adenovirus E1A/E1B 157
Transformation of hamster kidney cells by fragments of BK virus DNA 157
Cooperation in oncogenesis between BK virus early region gene and the activated human c-Harvey RAS oncogene 157
Transformation of human embryonic fibroblasts by BK virus, BK virus DNA and a subgenomic BK virus DNA fragment 151
Adenovirus type 12 early region 1A proteins repress class I HLA expression in transformed human cells 147
Prevalence of liver tumours in HIV-1 tat-transgenic mice treated with urethane 145
EFFECT OF TAT TRANSDOMINANT NEGATIVE MUTANTS ON HIV-1 REPLICATION IN JURKAT T-CELL LINES 144
Complex associates of plasmid DNA and a novel class of block copolymers with PEG and cationic segments as new vectors for gene delivery 138
Inhibition of HIV-1 replication and reactivation from latency by tat transdominant negative mutants in the cysteine rich region 136
The tat gene and protein of the human immunodeficiency virus type 1. 133
The Tat Protein of HIV-1 Prevents the Loss of HSV-Specific Memory Adaptive Responses and Favors the Control of Viral Reactivation 132
DNA immunization with HIV-1 tat mutated in the transactivation domain induces humoral and cellular immune response against wild-type Tat 131
Age differentially impacts adaptive immune responses induced by adenoviral versus mRNA vaccines against COVID-19 130
Recent Advances In The Development Of HIV-1 Tat-Based Vaccines 130
The human immunodeficiency virus type-1 Tat protein upregulates Bcl-2 gene expression in Jurkat T-cell lines and primary peripheral blood mononuclear cells 130
Impaired Priming of SARS-CoV-2-Specific Naive CD8+ T Cells in Older Subjects 128
Ageing Curtails the Diversity and Functionality of Nascent CD8+ T Cell Responses against SARS-CoV-2 126
Characterization of the effects of two polysulfonated distamycin A derivatives, PNU145156E and PNU153429, on HIV type 1 Tat protein 124
Effects of the age of vaccination on the humoral responses to a human papillomavirus vaccine 121
The HIV-1 tat gene as a target for gene therapy and analysis of its role in cell proliferation 118
Interferon regulatory factor-1 acts as a powerful adjuvant in tat DNA based vaccination 117
Altered Basal Lipid Metabolism Underlies the Functional Impairment of Naive CD8+ T Cells in Elderly Humans 117
Inhibition of human immunodeficiency virus reactivation from latency by a tat transdominant negative mutant 116
Reexamination of the coding potential of the HTLV-1 pX region 116
Viral Vector Expressing Tat As Immunomodulatory Molecule Represent A New Vaccine Strategy Against HSV Infection 116
The HIV-1 regulatory genes tat and rev as targets for gene therapy 115
Induction of anti-Tat immune response in mice following inoculation of plasmid DNA expressing HIV-tat mutant genes. 115
Immobilized HIV-1 Tat protein promotes gene transfer via a transactivation-independent mechanism which requires binding of Tat to viral particles 115
Transactivation of BKV and SV40 early promoters by BKV and SV40 T-antigens 114
null 113
Induzione di una risposta immune in topi immunizzati con DNA plasmidici codificanti due mutanti transdominanti negativi del gene tat di HIV-1. 113
Preparation and characterization of innovative protein-coated poly(methylmethacrylate) core-shell nanoparticles for vaccine purposes 113
Vaccination with DNA containing tat coding sequences and unmethylated CpG motifs protects cynomolgus monkeys upon infection with simian/human immunodeficiency virus (SHIV89.6P) 111
null 110
Nanoparticle-Mediated Delivery of Antisense Oligoribonucleotides Allows Restoration of Dystrophin Expression in the mdx Mouse 109
Co-operation in cell transformation between BK virus and the human c-Harvey-ras oncogene 109
Presenza del virus BK in sarcomi di Kaposi. 108
Neutralizing and cross-neutralizing antibody titres induced by bivalent and quadrivalent human papillomavirus vaccines in the target population of organized vaccination programmes 107
In Chronic Hepatitis C Infection, Myeloid-Derived Suppressor Cell Accumulation and T Cell Dysfunctions Revert Partially and Late After Successful Direct-Acting Antiviral Treatment 107
Hpv-specific systemic antibody responses and memory b cells are independently maintained up to 6 years and in a vaccine-specific manner following immunization with cervarix and gardasil in adolescent and young adult women in vaccination programs in Italy 107
null 104
Formation of oligomeric free BK virus DNA is required for tandem integration of viral genomes into cellular DNA 104
null 103
Expression of hepatitis B surface antigen in human cells by a recombinant BK virus DNA vector 103
The Sp1 transcription factor does not directly interact with the HIV-1 Tat protein 103
Naïve CD8+ T-Cells Engage a Versatile Metabolic Program Upon Activation in Humans and Differ Energetically From Memory CD8+ T-Cells 103
Inhibition of HIV-1 tat activity correlates with down-regulation of bcl-2 and results in reduction of angiogenesis and oncogenicity 102
Functional polymeric nano/microparticles for surface adsorption and delivery of protein and DNA vaccines 102
null 101
Micellar-type complexes of tailor-made synthetic block copolymers containing the HIV-1 tat DNA for vaccine application 101
New BK virus episomal vector for complementary DNA expression in human cells 101
Core-shell microspheres by dispersion polymerization as promising delivery systems for proteins 99
Constitutive expression of hiv-1 tat protein in human jurkat t cells using a bk virus vector 99
Use of a Novel Peptide Welding Technology Platform for the Development of B- and T-Cell Epitope-Based Vaccines 99
Antiretroviral Therapy Partially Restores Phenotypic and Metabolic Immunosenescence Features of T Cells in Hiv Infected Individuals 98
HIV-1 Tat-Based Vaccines: From Basic Science to Clinical Trials 97
Transformation of hamster kidney cells by a fragment of BK virus DNA containing the entire early region 96
Induction of malignant subcutaneous sarcomas in hamsters by a recombinant DNA containing BK virus early region and the activated human c-Harvey-ras oncogene 96
The expression of P-glycoprotein is causally related to a less aggressive phenotype in human osteosarcoma cells 96
DNA prime and protein boost immunization with innovative polymeric cationic core-shell nanoparticles elicits broad immune responses and strongly enhance cellular responses of HIV-1 tat DNA vaccination 96
null 95
Pentosan Polysulfate as an Inhibitor of Extracellular HIV-1 Tat 95
Inhibition of human immunodeficiency virus reactivation from latency by tat antisense RNA and a tat transdominant negative mutant 95
null 94
Interaction of Sp1 transcription factor with HIV-1 Tat protein: Looking for cellular partners 94
Modulation of Th1/Th2 immune responses to HIV-1 Tat by new pro-GSH molecules 93
The increase in intra-macrophage thiols induced by new pro-GSH molecules directs the Th1 skewing in ovalbumin immunized mice 93
Studies on the effect of the combined expression of anti-tat and anti-rev genes on HIV-1 replication 92
null 91
Characterization of HIV-1 Tat proteins mutated in the transactivation domain for prophylactic and therapeutic application 91
Vaccines containing the HIV tat protein as an adjuvant for the enhancement of cytotoxic T-cell responses 91
null 90
Totale 14.015
Salva come PNG Salva come JPEG
Categoria #
all - tutte 88.081
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 2.926
Totale 91.007
Salva come PNG Salva come JPEG


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2020/20211.043 0 0 0 0 0 153 109 219 72 237 157 96
2021/20221.319 38 111 73 82 29 53 68 114 61 115 106 469
2022/2023933 140 37 54 103 130 118 59 97 113 9 47 26
2023/2024644 63 80 33 23 44 143 25 36 20 17 11 149
2024/20252.923 91 70 240 100 332 225 114 108 460 405 469 309
2025/20264.133 840 313 746 1.014 1.095 125 0 0 0 0 0 0
Totale 17.835